Navigation Links
Circadian Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients
Date:1/8/2012

MELBOURNE, Australia, Jan. 8, 2012 /PRNewswire/ -- Circadian Technologies Limited (ASX:CIR, OTCQX:CKDXY) announced today that it has commenced the first Phase 1 clinical trial of its fully human monoclonal antibody against VEGF-C, VGX-100, at a leading US-based cancer treatment centre.

The Phase 1 study will examine the safety and tolerability of escalating doses of VGX-100 in patients with advanced solid tumours who have no other standard treatment options both as a monotherapy and also when used in combination with other anti-angiogenic agents.  Results from the trial are expected to be available in the second half of 2012.

"We are extremely proud to have completed the translation of VGX-100 from early discovery to the clinical development stage. We are committed to improving outcomes for patients suffering from cancer, and believe that VGX-100, especially when combined with existing therapies could make a significant difference. Commencing clinical trials with VGX-100 is an extremely important achievement for Circadian and a major step in our goal to develop VGX-100 as a new therapeutic agent in the fight against cancer," said Robert Klupacs, CEO of Circadian Technologies Limited.

VGX-100 is a human antibody that acts against the human VEGF-C protein.  Treatment for cancers, particularly glioblastoma and metastatic colorectal cancers, are the first target indications for VGX-100. Additionally, Circadian is developing VGX-100 for a number of other cancer indications, as well as an agent to treat front-of the-eye diseases.

Studies in animal model studies across a wide range of tumour types have shown that when combined with Avastin® and/or chemotherapy, VGX-100 can significantly reduce tumour growth and tumour spread as well as significantly improve tumour inhibition over and above that of Avastin® and/or chemotherapy alone. Recent studies have also implicated VEGF-C as a key mediator of disease
'/>"/>

SOURCE Circadian Technologies Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Circadiance Launches Revolutionary New CPAP Tube
2. Circadian Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors
3. Circadian Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors
4. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
5. Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix
6. Coronado Biosciences Commences Public Trading on the OTC Bulletin Board
7. Hotspur Technologies Commences US Launch at Veith/AIM Conference in New York City
8. CryoLife Commences Tender Offer for All Outstanding Shares of Cardiogenesis Corporation
9. Unilife Commences Initial Production of Unifill Prefilled Syringe
10. Quest Diagnostics Commences Tender Offer for Acquisition of Celera
11. Milestone Scientific Inc. Commences Trading on the OTC Pink
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 When they began experiencing significant ... vendor their system would no longer be supported, ... a better structured solution to support their radiology ... to its interface capabilities and its 2014 EHR ... to the hospital,s radiology department. Avreo,s experienced team ...
(Date:3/26/2015)... -- Desert Valley Medical Center, named a Top 100 Hospitals® ... first U.S. hospital to deploy the wireless Leaf Patient ... prevent hospital acquired pressure ulcers. Desert Valley, ... a community hospital serving some higher risk populations, including ... in the hospital,s emergency department enables the clinical staff ...
(Date:3/26/2015)... , March 26, 2015  The inaugural ... use of health technology innovations that improve clinical ... collaborations to improve development and adoption of novel ... structures and processes within delivery systems that will ... investors, entrepreneurs, developers and other stakeholders, takes place ...
Breaking Medicine Technology:Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 2HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 3HX360 To Highlight New, Innovative Technology-Based Solutions To Improve Care Coordination, Workflow, Patient Experience 4
... Reportlinker.com announces that a new ... its catalogue: Epidemiology: ... risk factor for deep vein thrombosis ... http://www.reportlinker.com/p0536561/Epidemiology-Major-Abdominal-Surgery-–-A-key-risk-factor-for-deep-vein-thrombosis-and-pulmonary-embolism.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ...
... 2011 Zimmer Holdings, Inc. (NYSE and SIX: ZMH), ... will be participating in the Goldman Sachs 32nd Annual ... Palos Verdes, California, on June 7, 2011, at 8:40 ... of the presentation can be accessed via Zimmer,s Investor ...
Cached Medicine Technology:Reportlinker Adds Epidemiology: Major Abdominal Surgery - A key risk factor for deep vein thrombosis and pulmonary embolism 2Zimmer Holdings to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference 2
(Date:3/26/2015)... (PRWEB) March 26, 2015 Saving Moses ... where it is most needed but least available. As ... milk to six clinics in the Benguela province of ... malnutrition. During a recent visit to their clinics, staff ... the mothers and their babies in a nation the ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... 30th “Introduction to Hyperbaric Medicine” course, which is ... Society (UHMS) and the National Board of Diving ... the 40-hour course 4 times a year at ... the NY tri-state region; registration is available on-line ...
(Date:3/26/2015)... Altamonte Springs, FL (PRWEB) March 26, 2015 ... one of the nation’s leading innovative specialty pharmacies, ... newly created position of Vice President of Pharmaceutical ... for fostering beneficial connections with our pharmaceuticals partners ... pharmaceutical relationships in support of BioPlus’ expansion. ...
(Date:3/26/2015)... 2015 The Pulmonary Hypertension ... to Treatments Act (PATA) that was introduced in ... David B. McKinley (R-WV) and Lois Capps (D-CA). ... for medications placed in a specialty tier and ... out-of-pocket expenses. , This legislation is critical to ...
(Date:3/26/2015)... 26, 2015 Documentation topped the ... and Assisted Living facilities during 2014, despite the ... the year. The survey queried Administrators, Directors ... coordinators, CNA’s and the variety of other interested ... website ( http://www.harmony-healthcare.com ) or participate in the ...
Breaking Medicine News(10 mins):Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 2Health News:Harmony Healthcare International Releases 2015 Post Acute Care Trends Report 3
... zebrafish just may give scientists one solution to information ... throughput screening, which uses robotics and computers to rapidly ... compounds that are best at destroying cancer or restoring ... research, said Dr. Jeffrey Mumm, biologist in the Medical ...
... , TUESDAY, Jan. 17 (HealthDay News) -- Young and middle-aged ... time may be at increased risk for accidental falls, a new ... elderly people, according to the report published online Jan. 17 in ... researchers looked at data from 344 working-age people who died or ...
... HealthDay Reporter , MONDAY, Jan. 16 (HealthDay News) -- Teenage ... to develop acne than their normal-weight peers, a new Norwegian ... specifically body mass index (BMI, a ratio of weight to ... skin condition among teens. Teens, responses to questionnaires focusing ...
... , MONDAY, Jan. 16 (HealthDay News) -- People ... experience changes in the brain as it adapts to shifts ... could prove useful in rehabilitation therapy for stroke or other ... right-handed people who suffered an upper-arm injury that required them ...
... study from the American Cancer Society finds recent declines ... U.S. mainly reflect declines in those with the highest ... melanoma mortality rates by education. The authors say the ... high-risk, low-educated, non-Hispanic White individuals. The study is published ...
... -- Variations in a certain gene can make people more or ... for obesity, researchers report. The team at the Washington University ... found that those with a particular variant of the CD36 gene ... is the first study to identify a receptor on human tongues ...
Cached Medicine News:Health News:Zebrafish may help speed drug discovery 2Health News:Younger Adults on Multiple Meds at Risk for Falls: Study 2Health News:Overweight Teen Girls May Have Higher Acne Risk 2Health News:Overweight Teen Girls May Have Higher Acne Risk 3Health News:Brain Structure Adapts to Arm Injury, Study Says 2Health News:Declines in melanoma deaths limited to the most educated 2Health News:Your Taste for Fat May Reside in Your Genes 2
Aaron Burr II with disposable 1mm burr for corneal rust ring removal and a diamond burr tip for polishing the pterygium bed after surgical removal and for lid margin lesions....
Algerbrush II corneal rust ring remover battery powered...
Non-Illuminated Trial Lens Set with lenses mounted in plastic frames....
Plus cylinders only trial lens set....
Medicine Products: